1. Главная
  2. Ресурсы
  3. Библиотечный поиск
NDY1/KDM2B Functionsas a Master Regulatorof Polycomb Complexesand ControlsSelf-Renewal ofBreast Cancer StemCells Filippos KottakisParthena FoltopoulouIoannis Sanidas2014 год

NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
статья из журнала

Полный текстСтраница публикацииПубликация в OpenAlex
Аннотация: The JmjC domain histone H3K36me2/me1 demethylase NDY1/KDM2B is overexpressed in various types of cancer. Here we show that knocking down NDY1 in a set of 10 cell lines derived from a broad range of human tumors inhibited their anchorage-dependent and anchorage-independent growth by inducing senescence and/or apoptosis in some and by inhibiting G1 progression in all. We further show that the knockdown of NDY1 in mammary adenocarcinoma cell lines decreased the number, size, and replating efficiency of mammospheres and downregulated the stem cell markers ALDH and CD44, while upregulating CD24. Together, these findings suggest that NDY1 is required for the self-renewal of cancer stem cells and are in agreement with additional findings showing that tumor cells in which NDY1 was knocked down undergo differentiation and a higher number of them is required to induce mammary adenocarcinomas, upon orthotopic injection in animals. Mechanistically, NDY1 functions as a master regulator of a set of miRNAs that target several members of the polycomb complexes PRC1 and PRC2, and its knockdown results in the de-repression of these miRNAs and the downregulation of their polycomb targets. Consistent with these observations, NDY1/KDM2B is expressed at higher levels in basal-like triple-negative breast cancers, and its overexpression is associated with higher rates of relapse after treatment. In addition, NDY1-regulated miRNAs are downregulated in both normal and cancer mammary stem cells. Finally, in primary human breast cancer, NDY1/KDM2B expression correlates negatively with the expression of the NDY1-regulated miRNAs and positively with the expression of their PRC targets.
Год издания: 2014
Авторы: Filippos Kottakis, Parthena Foltopoulou, Ioannis Sanidas, Patricia J. Keller, Ania Wronski, Benjamin T. Dake, Scott A. Ezell, Zhu Shen, Stephen P. Naber, Philip W. Hinds, Elizabeth A. McNiel, Charlotte Kuperwasser, Philip N. Tsichlis
Издательство: American Association for Cancer Research
Источник: Cancer Research
Ключевые слова: Epigenetics and DNA Methylation, Cancer Cells and Metastasis, Cancer Genomics and Diagnostics
Другие ссылки: Cancer Research (HTML)
Europe PMC (PubMed Central) (PDF)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
aacr.figshare.com (PDF)
doi.org (HTML)
aacr.figshare.com (PDF)
doi.org (HTML)
aacr.figshare.com (PDF)
doi.org (HTML)
aacr.figshare.com (PDF)
doi.org (HTML)
aacr.figshare.com (PDF)
doi.org (HTML)
aacr.figshare.com (PDF)
doi.org (HTML)
aacr.figshare.com (PDF)
doi.org (HTML)
aacr.figshare.com (PDF)
doi.org (HTML)
aacr.figshare.com (PDF)
doi.org (HTML)
PubMed (HTML)